 |
Previous Article | Next Article 
Volume 17, Number 20,
Issue of October 15, 1997
pp. 7754-7762
Copyright ©1997 Society for Neuroscience
Neurons Promote the Translocation of Peripheral Myelin Protein 22 into Myelin
Received March 9, 1997; revised June 24, 1997; accepted Aug. 7, 1997.
Sangeeta Pareek1,
Lucia Notterpek2,
G. Jackson Snipes1,
Roland Naef3,
Wayne Sossin1,
Jacynthe Laliberté1,
Sandra Iacampo1,
Ueli Suter3,
Eric M. Shooter2, and
Richard A. Murphy1
1 Montreal Neurological Institute and the Faculty of
Medicine, McGill University, Montreal, Quebec H3A 2B4, Canada,
2 Department of Neurobiology, Stanford University School of
Medicine, Stanford, California 94305, and 3 Institute of
Cell Biology, Swiss Federal Institute of Technology,
ETH-Hönggerberg, CH-8093 Zürich, Switzerland
Schwann cells express low levels of myelin proteins in the absence
of neurons. When Schwann cells and neurons are cultured together the
production of myelin proteins is elevated, and myelin is formed. For
peripheral myelin protein 22 (PMP22), the exact amount of protein
produced is critical, because peripheral neuropathies result from its
underexpression or overexpression. In this study we examined the effect
of neurons on Schwann cell PMP22 production in culture and in
peripheral nerve using metabolic labeling and pulse-chase studies as
well as immunocytochemistry. Most of the newly synthesized PMP22 in
Schwann cells is rapidly degraded in the endoplasmic reticulum. Only a
small proportion of the total PMP22 acquires complex glycosylation and
accumulates in the Golgi compartment. This material is translocated to
the Schwann cell membrane in detectable amounts only when axonal
contact and myelination occur. Myelination does not, however, alter the
rapid turnover of PMP22 in Schwann cells. PMP22 may therefore be a
unique myelin protein in that axonal contact promotes its insertion
into the Schwann cell membrane and myelin without altering its rapid
turnover rate within the cell.
Key words:
Schwann cells;
PMP22;
glycosylation;
turnover;
Golgi;
axonal contact
This article has been cited by other articles:

|
 |

|
 |
 
J. Li, K. Ghandour, D. Radovanovic, R. R. Shy, K. M. Krajewski, M. E. Shy, and G. A. Nicholson
Stoichiometric Alteration of PMP22 Protein Determines the Phenotype of Hereditary Neuropathy With Liability to Pressure Palsies
Arch Neurol,
July 1, 2007;
64(7):
974 - 978.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Amici, W. A. Dunn Jr, A. J. Murphy, N. C. Adams, N. W. Gale, D. M. Valenzuela, G. D. Yancopoulos, and L. Notterpek
Peripheral Myelin Protein 22 Is in Complex with {alpha}6beta4 Integrin, and Its Absence Alters the Schwann Cell Basal Lamina
J. Neurosci.,
January 25, 2006;
26(4):
1179 - 1189.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Pietila, J. T. Tuusa, P. M. Apaja, J. T. Aatsinki, A. E. Hakalahti, H. J. Rajaniemi, and U. E. Petaja-Repo
Inefficient Maturation of the Rat Luteinizing Hormone Receptor: A PUTATIVE WAY TO REGULATE RECEPTOR NUMBERS AT THE CELL SURFACE
J. Biol. Chem.,
July 15, 2005;
280(28):
26622 - 26629.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Roux, S. A. Amici, B. S. Fletcher, and L. Notterpek
Modulation of Epithelial Morphology, Monolayer Permeability, and Cell Migration by Growth Arrest Specific 3/Peripheral Myelin Protein 22
Mol. Biol. Cell,
March 1, 2005;
16(3):
1142 - 1151.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Fortun, W. A. Dunn Jr, S. Joy, J. Li, and L. Notterpek
Emerging Role for Autophagy in the Removal of Aggresomes in Schwann Cells
J. Neurosci.,
November 19, 2003;
23(33):
10672 - 10680.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. A. Street, C. L. Bennett, J. D. Goldy, A. J. Shirk, K. A. Kleopa, B. L Tempel, H. P. Lipe, S. S. Scherer, T. D. Bird, and P. F. Chance
Mutation of a putative protein degradation gene LITAF/SIMPLE in Charcot-Marie-Tooth disease 1C
Neurology,
January 14, 2003;
60(1):
22 - 26.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Notterpek, K. J. Roux, S. A. Amici, A. Yazdanpour, C. Rahner, and B. S. Fletcher
Peripheral myelin protein 22 is a constituent of intercellular junctions in epithelia
PNAS,
November 15, 2001;
(2001)
251548398.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Kamholz, D. Menichella, A. Jani, J. Garbern, R. A. Lewis, K. M. Krajewski, J. Lilien, S. S. Scherer, and M. E. Shy
Charcot-Marie-Tooth disease type 1: Molecular pathogenesis to gene therapy
Brain,
February 1, 2000;
123(2):
222 - 233.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Tobler, L. Notterpek, R. Naef, V. Taylor, U. Suter, and E. M. Shooter
Transport of Trembler-J Mutant Peripheral Myelin Protein 22 Is Blocked in the Intermediate Compartment and Affects the Transport of the Wild-Type Protein by Direct Interaction
J. Neurosci.,
March 15, 1999;
19(6):
2027 - 2036.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Notterpek, K. J. Roux, S. A. Amici, A. Yazdanpour, C. Rahner, and B. S. Fletcher
Peripheral myelin protein 22 is a constituent of intercellular junctions in epithelia
PNAS,
December 4, 2001;
98(25):
14404 - 14409.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|